Works matching IS 15268209 AND DT 2012 AND VI 12 AND IP 2


Results: 13
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Phase II interventional study (N0337) of capecitabine in combination with vinorelbine and trastuzumab for first- or second-line treatment of HER2-positive metastatic breast cancer: a north central cancer treatment group trial.

    Published in:
    2012
    By:
    • Tan WW;
    • Allred JB;
    • Salim M;
    • Flynn P;
    • Fishkin PA;
    • Stella PJ;
    • Wiesenfeld M;
    • Bernath AM;
    • Fitch TR;
    • Perez EA;
    • Tan, Winston W;
    • Allred, Jacob B;
    • Salim, Muhammad;
    • Flynn, Patrick;
    • Fishkin, Paul A S;
    • Stella, Philip J;
    • Wiesenfeld, Martin;
    • Bernath, Albert M;
    • Fitch, Tom R;
    • Perez, Edith A
    Publication type:
    journal article
    12
    13